LivaNova (LIVN) Consolidated Net Income (2014 - 2026)
LivaNova (LIVN) reported Consolidated Net Income of $23.1 million for Q1 2026, up 107.07% on a YoY basis from $11.2 million in Q1 2025, and down 25.14% sequentially from $30.9 million in Q4 2025.
LivaNova (LIVN) Consolidated Net Income (2014 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Consolidated Net Income data on file, last reported at $23.1 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income rose 107.07% year-over-year to $23.1 million; the trailing twelve-month figure through Mar 2026 stood at $108.0 million (up 148.63% YoY), and the FY2025 full-year result was -$242.4 million, down 483.26% from the prior year.
- Consolidated Net Income retreated to $23.1 million in Q1 2026, from $30.9 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $55.9 million in Q4 2024 to a low of -$327.3 million in Q1 2025.
- A 5-year average of -$13.2 million and a median of $16.4 million in 2023 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income surged 1283.09% in 2024 and plunged 680.83% in 2025, its largest moves.
- Tracing LIVN's Consolidated Net Income over 5 years: stood at $1.7 million in 2022, then jumped by 867.81% to $16.4 million in 2023, then jumped by 241.72% to $55.9 million in 2024, then slumped by 44.69% to $30.9 million in 2025, then declined by 25.14% to $23.1 million in 2026.
- Business Quant data shows LIVN's Consolidated Net Income at $23.1 million in Q1 2026, $30.9 million in Q4 2025, and $26.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 273.95 Mn |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | 23.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.15 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 27.17 Mn |
| Mar 31, 2025 | -327.30 Mn |
| Dec 31, 2024 | 55.89 Mn |
| Sep 30, 2024 | 32.92 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | -41.92 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | -107.40 Mn |
| Jun 30, 2022 | 16.49 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2020 | -498,000.00 |
| Mar 31, 2020 | -995,000.00 |
| Dec 31, 2019 | 187,000.00 |